Cite

HARVARD Citation

    Sokol, H. et al. (2010). Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy. Gut. 59 (10), pp. 1363-1368. [Online]. 
  
Back to record